Anti-CCL3L3/464.2/ D17S1718 functional antibody

Anti-CCL3L3/464.2/ D17S1718 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to CCL3L3/CCL3L3 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE0749-Ab-1/ GM-Tg-hg-SE0749-Ab-2Anti-Human CCL3L3 monoclonal antibodyHuman
GM-Tg-rg-SE0749-Ab-1/ GM-Tg-rg-SE0749-Ab-2Anti-Rat CCL3L3 monoclonal antibodyRat
GM-Tg-mg-SE0749-Ab-1/ GM-Tg-mg-SE0749-Ab-2Anti-Mouse CCL3L3 monoclonal antibodyMouse
GM-Tg-cynog-SE0749-Ab-1/ GM-Tg-cynog-SE0749-Ab-2Anti-Cynomolgus/ Rhesus macaque CCL3L3 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE0749-Ab-1/ GM-Tg-felg-SE0749-Ab-2Anti-Feline CCL3L3 monoclonal antibodyFeline
GM-Tg-cang-SE0749-Ab-1/ GM-Tg-cang-SE0749-Ab-2Anti-Canine CCL3L3 monoclonal antibodyCanine
GM-Tg-bovg-SE0749-Ab-1/ GM-Tg-bovg-SE0749-Ab-2Anti-Bovine CCL3L3 monoclonal antibodyBovine
GM-Tg-equg-SE0749-Ab-1/ GM-Tg-equg-SE0749-Ab-2Anti-Equine CCL3L3 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE0749-Ab-1/ GM-Tg-hg-SE0749-Ab-2; GM-Tg-rg-SE0749-Ab-1/ GM-Tg-rg-SE0749-Ab-2;
GM-Tg-mg-SE0749-Ab-1/ GM-Tg-mg-SE0749-Ab-2; GM-Tg-cynog-SE0749-Ab-1/ GM-Tg-cynog-SE0749-Ab-2;
GM-Tg-felg-SE0749-Ab-1/ GM-Tg-felg-SE0749-Ab-2; GM-Tg-cang-SE0749-Ab-1/ GM-Tg-cang-SE0749-Ab-2;
GM-Tg-bovg-SE0749-Ab-1/ GM-Tg-bovg-SE0749-Ab-2; GM-Tg-equg-SE0749-Ab-1/ GM-Tg-equg-SE0749-Ab-2
Products NameAnti-CCL3L3 monoclonal antibody
Formatmab
Target NameCCL3L3
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-CCL3L3 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE0749-Ag-1Recombinant multi-species CCL3L3/464.2/ D17S1718 protein


    Target information

    Target IDGM-SE0749
    Target NameCCL3L3
    Gene ID414062
    Gene Symbol and Synonyms464.2,CCL3L3,D17S1718,G0S19-2,LD78,LD78BETA,SCYA3L,SCYA3L1
    Uniprot AccessionN/A
    Uniprot Entry Name
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000276085
    Target ClassificationN/A

    The target: CCL3L3, gene name: CCL3L3, also named as 464.2, D17S1718, G0S19-2, LD78, LD78BETA, SCYA3L, SCYA3L1. This gene is one of several cytokine genes that are clustered on the q-arm of chromosome 17. Cytokines are a family of secreted proteins that function in inflammatory and immunoregulatory processes. The protein encoded by this gene binds to several chemokine receptors, including chemokine binding protein 2 and chemokine (C-C motif) receptor 5 (CCR5). CCR5 is a co-receptor for HIV, and binding of this protein to CCR5 inhibits HIV entry. The copy number of this gene varies among individuals, where most individuals have one to six copies, and a minority of individuals have zero or more than six copies. There are conflicting reports about copy number variation of this gene and its correlation to disease susceptibility.[provided by RefSeq, Apr 2014].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.